WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Tourism market makes robust recovery over holidayWorks from Fine Arts Exhibition of Chinese Women ArtistsCouncilors vow to explain Article 23 to HK residentsChina's thriving tech innovation a boon for emerging business formsXi, Peng Liyuan extend Chinese New Year greetings to U.S. Lincoln High School teachers, studentsHong Kong holds digital economy summit, eyes sustainable futureBridge on Xiong'an Expressway in placeTikTok affirms commitment to upholding online safetyChinese company signs MoU with Ethiopia to light up offKing Charles diagnosed with cancer, halts duties
2.26s , 6498.0078125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Stellar Stories news portal